32 results
Keyword epoetin Remove keyword
Responsible body
CHMP Remove CHMP filter
-
List item
Press release: EMEA recommends a new warning for epoetins for their use in cancer patients
CHMP, Last updated: 26/06/2008recommends a new warning for epoetins for their use in cancer patie … recommends a new warning for epoetins for their use in cancer patie … recommends a new warning for epoetins for their use in cancer patients … -
List item
News: Public Statement: Epoetins and the risk of tumour growth progression and thromboembolic events in cancer patients and cardiovascular risks in patients with chronic kidney disease
CHMP, Last updated: 23/10/2007Public Statement: Epoetins and the risk of tumour growth … Public Statement: Epoetins and the risk of tumour growth … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018
CHMP, Last updated: 27/07/2018Epoetin alfa Hexal, Kalydeco, Mekinist … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,23-26 June 2008
CHMP, Last updated: 26/06/2008recommended a new warning for epoetin-containing medicines. These medicines … QUESTIONS AND ANSWERS ON EPOETINS AND THE RISK OF TUMOUR … has reviewed the safety of epoetins used in cancer patients … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 July 2012
CHMP, Last updated: 20/07/2012methoxy polyethylene glycol-epoetin beta, peginterferon alfa-2a … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)20-23 June 2011
CHMP, Last updated: 24/06/2011epoetin zeta), from Hospira UK Ltd … neuropathy. Retacrit (epoetin zeta), from Hospira UK Ltd … -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 July 2017
European Medicines Agency, London, UK, from 17/07/2017 to 20/07/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 14-17 September 2020
Virtual meeting, from 14/09/2020 to 17/09/2020, Last updated: 14/09/2020 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 September 2018
European Medicines Agency, London, UK, from 17/09/2018 to 20/09/2018, Last updated: 31/10/2018 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,18-21 June 2007
CHMP, Last updated: 22/06/2007medicinal products. Binocrit (Epoetin alfa), from Sandoz GmbH Epoetin alfa Hexal Epoetin alfa), from Hexal Biotech … -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 May 2017
European Medicines Agency, London, UK, from 15/05/2017 to 18/05/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 December 2013
European Medicines Agency, London, UK, from 16/12/2013 to 19/12/2013, Last updated: 09/07/2012 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 July 2018
European Medicines Agency, London, UK, from 23/07/2018 to 26/07/2018, Last updated: 06/01/2014 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 October 2007
CHMP, Last updated: 18/10/2007medicinal product Silapo [epoetin zeta (rhEPO)], from Stada … Arzneimittel AG, and Retacrit [epoetin zeta (rhEPO)], from Hospira … -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 March 2017
European Medicines Agency, London, UK, from 20/03/2017 to 23/03/2017, Last updated: 20/03/2017 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 May 2007
CHMP, Last updated: 25/05/2007methoxy polyethylene glycol-epoetin beta), from Roche Registration … -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2011
European Medicines Agency, London, UK, from 20/06/2011 to 23/06/2011, Last updated: 11/06/2010neuropathy. Retacrit (epoetin zeta), from Hospira UK Ltd … -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 April 2011
European Medicines Agency, London, UK, from 11/04/2011 to 14/04/2011, Last updated: 11/06/2010authorisation for Epostim (epoetin alfa), intended to be used … -
List item
Committee for Medicinal Products for Human Use (CHMP): 6-9 November 2017
European Medicines Agency, London, UK, from 06/11/2017 to 09/11/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2017
European Medicines Agency, London, UK, from 23/01/2017 to 26/01/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 January 2014
European Medicines Agency, London, UK, from 20/01/2014 to 23/01/2014, Last updated: 09/08/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 February 2017
European Medicines Agency, London, UK, from 20/02/2017 to 23/02/2017, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 April 2018
European Medicines Agency, London, UK, from 23/04/2018 to 26/04/2018, Last updated: 08/06/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2018
European Medicines Agency, London, UK, from 19/02/2018 to 22/02/2018, Last updated: 06/04/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 December 2017
European Medicines Agency, London, UK, from 11/12/2017 to 14/12/2017, Last updated: 06/01/2014